Journal
JOURNAL OF ASTHMA
Volume 59, Issue 9, Pages 1908-1913Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/02770903.2021.1968895
Keywords
Cross-sectional; prospective cohort study; patient-reported outcomes; registry
Categories
Funding
- Italian Respiratory Society
- Italian Society of Allergology, Asthma and Clinical Immunology
Ask authors/readers for more resources
This study in Italy aims to investigate the clinical status and disease progression of patients with mild-to-moderate asthma, analyzing the epidemiological evolution and treatment response through observational research, exploring the impact of environmental and lifestyle factors on asthma.
Objective The prevalence of asthma in Italy is estimated to be around 4%; it affects approximately 2,000,000 citizens, and up to 80-90% of patients have mild-to-moderate asthma. Despite the clinical relevance of mild-to-moderate asthma, longitudinal observational data are very limited, including data on disease progression (worsening vs. improvement), the response to treatment, and prognosis. Studies are needed to develop long-term, observational, real-life research in large cohorts. The primary outcomes of this study will be based on prospective observation and the epidemiological evolution of mild and moderate asthma. Secondary outcomes will include patient-reported outcomes, treatments over time, disease-related functional and inflammatory patterns, and environmental and life-style influences. Methods This study, called the Mild/Moderate Asthma Network of Italy (MANI), is a research initiative launched by the Italian Respiratory Society and the Italian Society of Allergology, Asthma and Clinical Immunology. MANI is a cluster-based, real world, cross-sectional, prospective, observational cohort study that includes 20,000 patients with mild-to-moderate asthma. (ClinicalTrials.gov Identifier: NCT04796844). Results and conclusion Despite advances in asthma care, several research gaps remain to be addressed through clinical research. This study will add important new knowledge about long-term disease history, the transferability of clinical research results to daily practice, the efficacy of currently recommended strategies, and their impact on the burden and evolution of the disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available